Passage BIO

/Passage BIO

IPO

Passage BIO

Biotechnology

We are a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system, or CNS, disorders with limited or no approved treatment options.

Symbol

PASG

Price Range
$16.00 - $18.00

Final Shares
7,400,000

Anticipated Date
February 28, 2020

Underwriters
J.P. MORGAN SECURITIES LLC,GOLDMAN SACHS & CO. LLC

This offering is no longer available

To view the prospectus for Passage BIO IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253